Toxicology Drug Testing Market Revenue to Cross USD 55.9 billion by 2031, Growing at a CAGR of 5.5% Says Transparency Market Research
28 août 2023 04h17 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global toxicology drug testing market is projected to flourish at a CAGR of 5.5% from...
Global Allergy Diagnostics Market Is Expected to Generate $16.7 Billion by 2031: Allied Market Research
20 sept. 2022 11h00 HE
|
Allied Market Research
Portland, OR, Sept. 20, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Allergy Diagnostics Market garnered $5.0 billion in 2021, and is estimated to...
Inotiv, Inc. Continues to Expand Genetic Toxicology Offering with Support of GLP Assays at Rockville, MD, Location
26 juil. 2022 08h33 HE
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., July 26, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
In Vitro Diagnostics Market is expected to grow from USD 109.70 billion in 2021 to USD 132.63 billion by 2029, at a CAGR of 2.6% during the forecast period 2022-2029 : GreyViews
21 juil. 2022 06h15 HE
|
GreyViews
Pune India, July 21, 2022 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and Middle East...
Hardy Diagnostics Now Offers the BioCode® MDx-3000
14 mars 2022 07h00 HE
|
Hardy Diagnostics
SANTA MARIA, Calif., March 14, 2022 (GLOBE NEWSWIRE) -- Hardy Diagnostics, a leader in manufactured and distributed microbiology products, is pleased to announce it is now the exclusive distributor...
Im The New England Journal of Medicine veröffentlichte in-vitro-Daten zeigen, dass Seren von mit dem Pfizer-BioNTech COVID-19-Impfstoff geimpften Personen SARS-CoV-2 mit der Südafrika-Spike-Mutation neutralisieren
17 févr. 2021 17h13 HE
|
BioNTech SE
New York, USA und Mainz, DEUTSCHLAND, 17. Februar 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX) gaben heute Ergebnisse einer in-vitro-Studie bekannt, die zusätzliche...
In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations
17 févr. 2021 17h13 HE
|
BioNTech SE
New York, NY and Mainz, Germany, February 17, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study that provides additional...
Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification
21 déc. 2020 08h30 HE
|
Beroni Group Limited
NEW YORK and SYDNEY, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the...
Business Capital Delivers Financing for Bay Area Medical Clinic
12 févr. 2020 05h00 HE
|
Business Capital
SAN FRANCISCO, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Business Capital structured and delivered approximately $6MM in senior secured loans for NOVA IVF, a clinic established in 1987, providing in vitro...
Predictive Technology Group, Inc. (PRED) Announces Completion of Genotyping in Two Clinical Trials of ARTGuide™
20 févr. 2018 09h00 HE
|
PREDICTIVE TECHNOLOGY GROUP, INC.
SALT LAKE CITY, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED) announces that Predictive Therapeutics, LLC, its wholly-owned subsidiary, completed a crucial...